Debt-to-equity in % of Klotho Neurosciences, Inc. from Q1 2023 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Klotho Neurosciences, Inc. quarterly Debt-to-equity history and growth rate from Q1 2023 to Q3 2025.
  • Klotho Neurosciences, Inc. Debt-to-equity for the quarter ending September 30, 2025 was 17.7 %, a 99.1% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)

Klotho Neurosciences, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 17.7 -1.88K -99.1% Sep 30, 2025
Q2 2025 34.6 -28.2K -99.9% Jun 30, 2025
Q1 2025 547 +1.09K Mar 31, 2025
Q4 2024 1.07K +1.95K Dec 31, 2024
Q3 2024 1.9K +2.52K Sep 30, 2024
Q2 2024 28.3K +28.7K Jun 30, 2024
Q1 2024 -545 -59.1 -12.1% Mar 31, 2024
Q4 2023 -878 Dec 31, 2023
Q3 2023 -617 Sep 30, 2023
Q2 2023 -450 Jun 30, 2023
Q1 2023 -486 Mar 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.